UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
May 30, 2017
Date of Report (Date of earliest event reported)
INVIVO THERAPEUTICS HOLDINGS CORP.
(Exact Name of Registrant as Specified in Charter)
Nevada |
|
001-37350 |
|
36-4528166 |
(State or Other |
|
(Commission File Number) |
|
(IRS Employer |
Jurisdiction of Incorporation) |
|
|
|
Identification No.) |
One Kendall Square, Suite B14402
Cambridge, Massachusetts 02139
(Address of Principal Executive Offices) (Zip Code)
(617) 863-5500
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
(a) On May 30, 2017, InVivo Therapeutics Holdings Corp. (the Company) held its 2017 Annual Meeting of Stockholders (the Annual Meeting). At the Annual Meeting, the Companys stockholders approved an amendment to the Companys Articles of Incorporation to increase the number of shares of authorized common stock from 50,000,000 to 100,000,000 shares (the Amendment). Following stockholder approval of the Amendment, a Certificate of Amendment to the Companys Article of Incorporation was filed with the Secretary of State of Nevada on June 1, 2017, at which time the Amendment became effective.
The Amendment is summarized in the Companys Proxy Statement. A copy of the Certificate of Amendment containing the Amendment is filed as Exhibit 3.1 to this Current Report on Form 8-K and incorporated herein by reference.
Item 5.07. Submission of Matters to a Vote of Security Holders.
Set forth below are the matters submitted to the stockholders at the Annual Meeting, all of which were approved:
· the election of three (3) Class III directors, each to serve on the Companys Board of Directors for a three-year term expiring at the Companys annual meeting of stockholders in 2020 or until his or her successor is duly elected and qualified, and one (1) Class II director to serve on the Companys Board of Directors for a two-year term expiring at the Companys annual meeting of stockholders in 2019 or until her successor is duly elected and qualified;
· the approval of the Amendment; and
· the ratification of the appointment of RSM US, LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2017.
The number of votes for, withheld or against and the number of abstentions and non-votes with respect to each matter are set forth below.
Election of Directors
Class III Nominees
|
|
For |
|
Withheld |
|
Broker
|
|
Mark D. Perrin |
|
7,960,898 |
|
1,449,133 |
|
15,374,240 |
|
C. Ann Merrifield |
|
8,203,206 |
|
1,206,825 |
|
15,374,240 |
|
Jeffrey S. Hatfield |
|
8,354,043 |
|
1,055,988 |
|
15,374,240 |
|
Class II Nominee
|
|
For |
|
Withheld |
|
Broker Non-Votes |
|
Christina Morrison |
|
8,354,925 |
|
1,055,106 |
|
15,374,240 |
|
Approval of Amendment to Articles of Incorporation
For: |
|
17,649,108 |
|
Against: |
|
6,794,291 |
|
Abstain: |
|
340,872 |
|
Ratification of the Appointment of RSM US, LLP as the Companys Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2017
For: |
|
22,212,899 |
|
Against: |
|
1,560,899 |
|
Abstain: |
|
1,010,473 |
|
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
3.1 |
Certificate of Amendment to Articles of Incorporation |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
INVIVO THERAPEUTICS HOLDINGS CORP. |
|
|
|
|
|
|
|
Date: June 1, 2017 |
By: |
/s/ Tamara Joseph |
|
|
Tamara Joseph |
|
|
|
|
|
SVP, General Counsel & Chief Compliance Officer |
Exhibit 3.1
BARBARA K. CEGAVSKE Secretary of State 202 North Carson Street Carson City, Nevada 89701-4201 (775) 684-5708 Website: www.nvsos.gov Certificate of Amendment (PURSUANT TO NRS 78.385 AND 78.390) USE BLACK INK ONLY - DO NOT HIGHLIGHT ABOVE SPACE IS FOR OFFICE USE ONLY Certificate of Amendment to Articles of Incorporation For Nevada Profit Corporations (Pursuant to NRS 78.385 and 78.390 - After Issuance of Stock) 1. Name of corporation: InVivo Therapeutics Holdings Corp. 2. The articles have been amended as follows: (provide article numbers, if available) Article IV shall be replaced with the following: FOURTH The total number of shares that this corporation is authorized to issue is One Hundred Million (100,000,000) shares of Common Stock having a par value of $0.00001 per share. 3. The vote by which the stockholders holding shares in the corporation entitling them to exercise at least a majority of the voting power, or such greater proportion of the voting power as may be required in the case of a vote by classes or series, or as may be required by the provisions of the articles of incorporation* have voted in favor of the amendment is: Majority of outstanding shares 4. Effective date and time of filing: (optional) Date: Time: (must not be later than 90 days after the certificate is filed) 5. Signature: (required) x Signature of Officer *If any proposed amendment would alter or change any preference or any relative or other right given to any class or series of outstanding shares, then the amendment must be approved by the vote, in addition to the affirmative vote otherwise required, of the holders of shares representing a majority of the voting power of each class or series affected by the amendment regardless to limitations or restrictions on the voting power thereof. IMPORTANT: Failure to include any of the above information and submit with the proper fees may cause this filing to be rejected. This form must be accompanied by appropriate fees. Nevada Secretary of State Amend Profit-After Revised: 1-5-15